StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Amgen (AMGN) Thoughts After Ph1 Data - Mizuho
September 9, 2019 7:53 AM
Mizuho Securities analyst Salim Syed reiterated a Neutral rating and $212.00 price target on Amgen (NASDAQ: AMGN) after the company ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Baird Reiterates Neutral Rating on Amgen (AMGN)
September 9, 2019 8:26 AM